Home > Journals > Minerva Anestesiologica > Past Issues > Minerva Anestesiologica 2010 November;76(11) > Minerva Anestesiologica 2010 November;76(11):937-44





A Journal on Anesthesiology, Resuscitation, Analgesia and Intensive Care

Official Journal of the Italian Society of Anesthesiology, Analgesia, Resuscitation and Intensive Care
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 2,623




Minerva Anestesiologica 2010 November;76(11):937-44


language: English

Pharmacogenetics and postoperative pain: a new approach to improve acute pain management

Allegri M. 1, De Gregori M. 1, 2, Niebel T. 1, 2, 3, Minella C. 1, Tinelli C. 4, Govoni S. 5, Regazzi M. 6, Braschi A. 1, 7

1 Department of Anesthesia and Intensive Care, IRCCS Policlinico S. Matteo, Pavia, Italy; 2 Department of Genetics and Microbiology, University of Pavia, Italy; 3 Department of Surgical Science, University of Pavia, Italy; 4 Clinical Epidemiology and Biometric Unit, IRCCS Policlinico S. Matteo, Pavia, Italy; 5 Department of Experimental and Applied Pharmacology, University of Pavia, Italy; 6 Unit of Clinical Pharmacokinetics, IRCCS Policlinico S. Matteo, Pavia, Italy; 7 Department of Resuscitation and Organ Transplantation Surgery Sciences, Section of Anesthesiology and Resuscitation, University of Pavia, Italy


Acute postoperative pain is a complex phenomenon that baffles the staff involved in both its prevention and treatment. Acute postoperative pain varies even among patients who underwent the same type of surgery, and it is now known to be caused by different factors, including genetic background. This review will focus on the most important genes correlated with inter-patient differences in both pain sensitivity and analgesic response. Pain therapy is often administered to patients who are also taking other types of medication; therefore, drug interactions must be considered. A genetic analysis of receptors, of drug transporters, and of metabolizing enzymes may be needed to establish the effective doses of each drug in the individual patient to prevent side effects and also to achieve pain relief in a shorter period of time, which may prevent acute pain from becoming chronic. The etiology of chronic pain has not been elucidated yet, but we know that genetic predisposition comes into play, together with other clinical factors. Clinical trials including genetic analysis could be extremely useful in optimizing the management of postoperative pain therapy.

top of page

Publication History

Cite this article as

Corresponding author e-mail